Scientists from Edith Cowan University (ECU) have discovered that naturally occurring sugar molecules in the human body could help predict serious diseases years before symptoms appear, opening the door to a new era of personalised and preventive medicine.

The research, conducted by ECU's School of Medical and Health Sciences, focuses on glycans – complex sugar chains that coat cells and proteins throughout the body. Long considered little more than biological decoration, glycans are now being recognised as active participants in the body's immune responses and disease processes.

According to the study, changes in these sugar molecules can serve as real-time indicators of a person's health status, providing insights that traditional genetic testing cannot offer. Unlike DNA, which remains relatively stable throughout life, glycan patterns continuously evolve in response to lifestyle factors, environmental exposures, ageing and the earliest stages of disease development.

Professor Wei Wang, who leads the Suboptimal Health and Glycomics Research Group within ECU's Centre for Precision Health, described the findings as a major breakthrough.

"Glycans aren't just sitting there. They're actively controlling how our immune system works and how diseases develop," Professor Wang said.

"We're finally seeing clear patterns, and it's a game changer."

One of the most promising findings from the research was that specific glycan patterns detected in blood samples could predict the development of type 2 diabetes up to 10 years before diagnosis. Researchers believe this early detection capability could dramatically shift healthcare from a model focused on treating illness to one centred on prevention.

"Instead of waiting for people to get sick, we could spot the risk early and step in sooner," Professor Wang explained.

Because glycan signatures are influenced by a combination of genetics, hormones, diet, stress and environmental factors, scientists say they may provide highly individualised health profiles. This could eventually enable doctors to develop tailored prevention strategies and treatment plans based on a patient's unique biological changes.

The findings were published in the prestigious scientific journal Nature Chemical Biology, highlighting growing international interest in the field of glycomics – the study of glycans and their role in human health.

Despite the excitement surrounding the discovery, researchers caution that more work remains before glycan testing becomes part of routine medical practice. Larger long-term studies and internationally accepted testing standards will be needed to validate the approach and ensure its reliability across diverse populations.

If future research confirms these findings, a simple blood test analysing sugar molecules could one day help identify disease risk years before conventional symptoms emerge, offering patients the opportunity to make lifestyle changes or receive treatment at a much earlier stage.

The study represents another significant contribution from Western Australian researchers to the rapidly evolving field of precision medicine and has the potential to reshape how doctors diagnose and prevent chronic disease in the future.